Azopharma Receives Manufacturing Approval from MHRA
Azopharma Drug Development Services has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for production of commercial product. The MHRA issued a Good Manufacturing Practice (GMP) certificate to Azopharma after the successful audit of its Hollywood facilities conducted in December of 2009. The MHRA found Azopharma's facilities, equipment and quality systems to be all compliant with the principles and guidelines of GMP.
With the recent management restructuring that has taken place in Azopharma, the MHRA's approval confirms the successful implementation of better processes and quality systems. Melissa Porazzo, VP of Corporate Compliance comments, "This is an exciting accomplishment for us. Our quality assurance and regulatory teams work diligently to maintain high quality standards and this certificate is evidence of the improvement of our quality systems".